Logo image
Tu Whakaruruhau: the evaluation of treatment outcomes for methamphetamine dependence in Aotearoa, New Zealand - study protocol for a prospective longitudinal cohort study and longitudinal qualitative study
Journal article   Open access   Peer reviewed

Tu Whakaruruhau: the evaluation of treatment outcomes for methamphetamine dependence in Aotearoa, New Zealand - study protocol for a prospective longitudinal cohort study and longitudinal qualitative study

David Newcombe, Sophia de Fossard, Rebecca McKetin, Vili Nosa, Varsha Parag, Te Ropu Poa, Rodrigo Ramalho, Braden Te Ao, Janie Sheridan, Carina Walters, …
BMC Health Services Research, Vol.25, pp.1-12
2025
PMID: 40855310
pdf
s12913-025-13233-31.49 MBDownloadView
Published VersionCC BY-NC-ND V4.0 Open Access

Abstract

methamphetamine use disorder treatment longitudinal cohort longitudinal qualitative Māori
Background Methamphetamine is the second most used illicit drug in Aotearoa New Zealand, after cannabis. Regular and heavy users of methamphetamine are likely to develop methamphetamine use disorder (MUD), and significant health and psychiatric harm. Effective treatments for MUD are limited, and relapses are common. Tū Whakaruruhau is a programme of research that aims to understand what treatment approaches are effective in managing MUD and related physical and psychological harms, in New Zealand. Methods Tū Whakaruruhau comprises two studies. The first study is a 24-month longitudinal cohort study that will follow people receiving treatment and those not in treatment for MUD (outpatient counselling, residential treatment, and detoxification) in the Auckland, Northland, and Waikato regions of New Zealand. Data collection will occur on entry to treatment (baseline), then 3-, 12-, and 24-months later. The primary outcome is self-reported methamphetamine use (days used in the past month) at 12-months. Secondary outcomes include psychiatric comorbidity, polydrug use, change in diagnosis of MUD, criminal involvement, healthcare utilisation, and expectations and experiences of treatment. Three hundred and twenty participants (50% indigenous Māori, 240 in the Treatment Group, 80 in the Non treatment Group) will be sought for 90% power on the primary outcome. The second study is a longitudinal qualitative study involving interviews at baseline, 6-, and 12-months with 30 participants (50% Māori) from the Treatment Group, to explore their expectations of treatment and lived experiences of treatment for MUD over time. Discussion This programme of work will provide the first evidence of treatment outcomes for MUD and the relative effectiveness of the current approaches to treating MUD, in the New Zealand context. It will provide information on what factors predict better and more equitable health outcomes. The incorporation of qualitative interviews will ensure that the participants’ treatment experiences are captured. This will inform perspectives about what treatment approaches work, and do not work, so that the most appropriate interventions are made available to support consumer needs. Findings will be incorporated into relevant reviews, informing practice and policy. Study registration Australian and New Zealand Clinical Trial Registry: ACTRN12623000438651p. Registered 1st May 2023.

Details

Metrics

1 File views/ downloads
6 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Web Of Science research areas
Health Care Sciences & Services

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image